Skip to main content
Equibles
NHTC logo

NHTC · Natural Health Trends Corp

Track NHTC — free

Use NHTC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.60 -0.01 (-0.62%)
Rebalance outlook locked
Market Cap
$13.81M
Shares
8.58M

NHTC metrics

72 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.61
Market cap
$13.81M

Price action

19 metrics
Price change (1W)
-8.5%
Price change (30D)
-12.5%
Price change (3M)
-37.6%
Price change (6M)
-49.1%
Price change (YTD)
-47.9%
Price change (1Y)
-63.4%
Trailing year
Price change (5Y)
-75.7%
52-week high
$4.72
52-week low
$1.55
Change from 52-week high
-65.9%
Change from 52-week low
+3.9%
Annualized volatility
75.9%
Beta
1.0
RSI (14D)
38.6
Price vs SMA 50
-9.1%
Price vs SMA 200
-41.1%
Avg volume (3M)
44,780
Relative volume
0.8
Average dollar volume
$81,754

Company

3 metrics
Sector
Consumer Cyclical
Industry
Internet Retail
Shares outstanding
8.58M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.4×
reciprocal yield 276.9%
P / book
0.8
reciprocal yield 119.2%
FCF yield
-53.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-8.4%

Historical valuation

8 metrics
P / E historical average (3Y)
137.5×
reciprocal yield 0.7%
P / E historical average (5Y)
118.3×
reciprocal yield 0.8%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
24.8%
Trailing 12 months
Payout ratio
—
Shareholder yield
56.2%
Dividend / share (TTM)
$0.40
Dividend growth YoY
-50.0%
Dividend growth streak
—
Last ex-dividend
2026-05-12

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
73.9%
Operating margin
-5.1%
Trailing 12 months
Net margin
-3.0%
Gross profit (TTM)
$28.25M
Operating profit (TTM)
−$1.94M
Net income (TTM)
−$1.16M
Trailing 12 months
Diluted EPS (TTM)
$-0.11
FCF margin
-19.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$8.69

Growth

11 metrics
Revenue growth YoY
-14.3%
Year over year
Net income growth YoY
-226.2%
Revenue (TTM)
$38.24M
Trailing 12 months
EPS growth YoY
-300.0%
Shares change YoY
-11.7%
Year over year · fewer shares
Revenue CAGR (3Y)
-6.8%
Revenue CAGR (5Y)
-8.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-7.0%
Return on assets
-3.6%
Debt / equity
—
Current ratio
2.0
EBITDA (TTM)
−$1.85M
Free cash flow (TTM)
−$7.45M
Quick ratio
1.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$21.23M
Latest balance sheet
Cash & equivalents
$9.22M
Total assets
$31.95M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$7.28M
Capital expenditures (TTM)
$167,000
R&D (TTM)
—
SG&A (TTM)
$14.52M
Stock compensation (TTM)
$98,000
R&D / revenue
—
Stock compensation / revenue
0.3%

Ownership (13F)

3 metrics
13F filers
23
13F filer change QoQ
-1
Institutional ownership
12.1%

Short interest

3 metrics
Short interest
0.4%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
31 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 912061 CUSIP 63888P406 13F (30d) 20 filings 20 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)